Skip Ribbon Commands
Skip to main content
Navigate Up
Sign In

Belgian Early Warning System on Drugs (BEWSD)

:

Latest news: Four new drugs go under the microscope in the wake of rising health concerns - 25I-NBOMe, AH-7921, MDPV and methoxetamine

Europe has responded to rising concern over the use of four new drugs by formally requesting a scientific investigation into the health and social risks of the substances. The decision was communicated to the EU drugs agency (EMCDDA) by the Council of the EU today, in line with a legal procedure designed to respond to potentially harmful new psychoactive drugs in the EU.
 
The Council requests the EMCDDA Scientific Committee to conduct formal risk assessments of the four new substances — 25I-NBOMe, AH-7921, MDPV and methoxetamine — after harmful effects related to the drugs were reported by the Member States and picked up by the EU Early-warning system.
The substances will be scrutinised by the Committee in Lisbon in April, with the participation of additional experts from the EU Member States, European Commission, Europol and the European Medicines Agency (EMA). More information can be found on the EMCDDA website.